FindTrial
Sign In

Real world Long term Follow-up Registry Study of Lung Cancer Patients in China:A Multicenter, Prospective, Non-interventional Study.

Real world Long term Follow-up Registry Study of Lung Cancer Patients in China:A Multicenter, Prospective, Non-interventional Study. - Real world Long term Follow-up Registry Study of Lung Cancer Patients in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125433
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Observation group:None

Sponsors

Peking University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with clinical or pathological diagnosis of lung cancer, including small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC); 2. Patients receiving medical treatment at medical institutions within the scope of this study; 3. Patients of Chinese nationality; 4. Patients who have signed the electronic informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who refuse long-term follow-up; 2. Patients with a history of mental illness who are unable to cooperate with follow-up; 3. Patients deemed ineligible for enrollment by investigators.

Design outcomes

Primary

MeasureTime frame
Clinical characteristics (pathological diagnosis results, clinical stage of lung cancer, TNM stage, comorbidities, treatment for comorbidities, vital signs, physical examination, laboratory tests, genetic testing, etc.);treatment patterns;—

Countries

China

Contacts

Public ContactZhao Jun

Peking University Cancer Hospital

ohjerry@163.com+86 10 8819 6456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026